AUTHOR=Serra-Vidal Mᵃdel Mar , Latorre Irene , Franken Kees L. C. M. , Díaz Jéssica , de Souza-Galvão Maria Luiza , Casas Irma , Maldonado José , Milà Cèlia , Solsona Jordi , Jimenez-Fuentes M. Ángeles , Altet Neus , Lacoma Alícia , Ruiz-Manzano Juan , Ausina Vicente , Prat Cristina , Ottenhoff Tom H. M. , Domínguez José TITLE=Immunogenicity of 60 novel latency-related antigens of Mycobacterium tuberculosis JOURNAL=Frontiers in Microbiology VOLUME=5 YEAR=2014 URL=https://www.frontiersin.org/journals/microbiology/articles/10.3389/fmicb.2014.00517 DOI=10.3389/fmicb.2014.00517 ISSN=1664-302X ABSTRACT=

The aim of our work here was to evaluate the immunogenicity of 60 mycobacterial antigens, some of which have not been previously assessed, notably a novel series of in vivo-expressed Mycobacterium tuberculosis (IVE-TB) antigens. We enrolled 505 subjects and separated them in individuals with and without latent tuberculosis infection (LTBI) vs. patients with active tuberculosis (TB). Following an overnight and 7 days stimulation of whole blood with purified recombinant M. tuberculosis antigens, interferon-γ (IFN-γ) levels were determined by ELISA. Several antigens could statistically significantly differentiate the groups of individuals. We obtained promising antigens from all studied antigen groups [dormancy survival regulon (DosR regulon) encoded antigens; resuscitation-promoting factors (Rpf) antigens; IVE-TB antigens; reactivation associated antigens]. Rv1733, which is a probable conserved transmembrane protein encoded in DosR regulon, turned out to be very immunogenic and able to discriminate between the three defined TB status, thus considered a candidate biomarker. Rv2389 and Rv2435n, belonging to Rpf family and IVE-TB group of antigens, respectively, also stood out as LTBI biomarkers. Although more studies are needed to support our findings, the combined use of these antigens would be an interesting approach to TB immunodiagnosis candidates.